Home › NDC Lookup › RxCUI directory › RxCUI 2571099

Tisotumab vedotin-tftv 40 MG Injection — RxCUI 2571099

Name: Tisotumab vedotin-tftv 40 MG Injection (RxCUI 2571099)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 2571099 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2571099

Official nameTisotumab vedotin-tftv 40 MG Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

FDA products mapped1

Package NDCs mapped1

Reported Medicaid activity (SDUD)321 prescriptions · 10 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

🕸️ Concept Web — How Tisotumab vedotin-tftv 40 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Tisotumab vedotin-tftv 40 MG Injection RxCUI 2571099 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Tisotumab 2571095 IN
- Tisotumab vedotin-tftv 2571093 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Tivdak 2571100 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Tisotumab Injection 2571098 SCDF
- Tisotumab vedotin-tftv Injection 2648408 SCDFP
- Tisotumab Injectable Product 2571097 SCDG
- Tisotumab vedotin-tftv Injectable Product 2663684 SCDGP
- Tisotumab Injection [Tivdak] 2571103 SBDF
- Tisotumab vedotin-tftv Injection [Tivdak] 2655426 SBDFP
- Tivdak Injectable Product 2571102 SBDG
- Injection 1649574 DF
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Tisotumab vedotin-tftv 40 MG 2571096 SCDC
- Tisotumab vedotin-tftv 40 MG Injection [Tivdak] 2571104 SBD
- Tisotumab vedotin-tftv 40 MG [Tivdak] 2571101 SBDC

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Tisotumab vedotin-tftv 40 MG SCDC · 2571096
Tisotumab Injection SCDF · 2571098
Tisotumab vedotin-tftv Injection SCDFP · 2648408
Tisotumab Injectable Product SCDG · 2571097
Tisotumab vedotin-tftv Injectable Product SCDGP · 2663684

Brand-Name Concepts

Tisotumab vedotin-tftv 40 MG Injection [Tivdak] SBD · 2571104
Tisotumab vedotin-tftv 40 MG [Tivdak] SBDC · 2571101
Tisotumab Injection [Tivdak] SBDF · 2571103
Tisotumab vedotin-tftv Injection [Tivdak] SBDFP · 2655426
Tivdak Injectable Product SBDG · 2571102
Tivdak BN · 2571100

📦 FDA Products & Package NDCs

1 product · 1 package NDC

1 package NDC map to RxCUI 2571099 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
51144-0003-01	1 VIAL in 1 CARTON (51144-003-01) / 4 mL in 1 VIAL	TIVDAK	SEAGEN INC.	2021-09-20

Observed labelers: SEAGEN INC. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J9273	Inj tisotu vedotin-tftv, 1mg	1	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.